Canadian amiodarone myocardial infarction arrhythmia trial (CAMIAT)
Jump to navigation
Jump to search
Introduction
Amiodarone did not improve overall mortality after myocardial infarction.
More general terms
References
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 67